Peter N. Johnson, Pharm.D., BCPPS, FPPAG, FCCM, FASHP
Professor of Pharmacy Practice
Pharmacy Clinical & Admin Sci
Phone (405) 271-2730
Fax (405) 271-6750
Office O'Donoghue Research Bldg; 1122 NE 13th St., Ste. 4415, OKC 73117
Email Peter-Johnson@ouhsc.edu
Summary
- President's Associate Presidential Professor
- Director, PGY2 Pediatric Pharmacy Residency
- Director, Pediatric Pharmacotherapy Degree Option
Publications & Presentations
- 51. Johnson P N, Stephens K, Barker P, Bergeron E, Lim S Y, Hagemann T M, Lewis T V, Neely S, Miller J L. Prescribing Patterns of Continuous Infusions in Nonobese versus Obese Children Admitted to the Pediatric Intensive Care Unit. Journal of pediatric intensive care. 2019; 8 : 226-232
52. Stephens K, Miller J L, Lewis T V, Neely S, Johnson P N. Hyponatremia With Intravenous Sulfamethoxazole/Trimethoprim in Children. The Annals of pharmacotherapy. 2019
53. Johnson P N, Miller J L. Small patients, big problems? Pediatric primer for the nonpediatric pharmacist. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2019; 76 : 1451-1452
54. Blackmer A B, Siu A, Thornton A, Johnson P N, Nichols K R, Hagemann T M. Academic Careers in Pediatric Pharmacy: Part 2-Academic Advancement. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2019; 24 : 183-193
55. Miller J L, Ernst K, Neely S, Stephens K, Barker P, Skrepnek G H, Johnson P N. Low-dose versus high-dose methadone for the management of neonatal abstinence syndrome. Journal of opioid management. 2019; 15 : 159-167
Grants
- 1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.
Awards and Honors
- 1. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Dom Ropp). Date: 2023.
2. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Eugenie Chang). Date: 2023.
3. University of Oklahoma College of Medicine--Department of Pediatrics. Mentor award (for Caitlyn Bradford, PharmD). Date: 2022.
4. University of Oklahoma Health Sciences Center. President's Associates Presidential Professorship. Date: 2019.
5. Pediatric Pharmacy Advocacy Group. Christensen Young Investigator Award (Served as resident mentor). Date: 2016.
Education
- 1. Degree: PGY2 Pediatric Pharmacy Residency. Kentucky Children's Hospital and University of Kentucky Chandler Medical Center. Date: 2006.
2. Degree: PGY1 Pharmacy Residency. University of Kentucky Chandler Medical Center. Date: 2005.
3. Degree: PharmD. University of Mississippi School of Pharmacy. Date: 2004.
4. Degree: BS. University of Mississippi School of Pharmacy. Date: 2002.
Administrative Assignments
no results